![](https://bioinorganica.ufc.br/wp-content/uploads/Screen-Shot-2022-05-27-at-20.57.20.png)
Galera Therapeutics, manganese-based compounds as SOD dismutase mimics for treatment of several oral mucositis, improving cancer treatment.
![](https://bioinorganica.ufc.br/wp-content/uploads/Screen-Shot-2022-05-28-at-10.29.25.png)
This company employs CO and other gases for therapy, including sickle cells disease, Parkinson’s disease, acute pain among others.
![](https://bioinorganica.ufc.br/wp-content/uploads/Screen-Shot-2022-05-27-at-21.09.11.png)
Cuprous Therapeutics, copper-based compounds and nanotechnology products for improving drugs and treatment of cancer and infectious diseases.
![](https://bioinorganica.ufc.br/wp-content/uploads/Screen-Shot-2022-05-28-at-10.20.32.png)
A UK startup dedicated to investigate therapies based on ruthenium for bacterial and resistant bacterial infections.
![](https://bioinorganica.ufc.br/wp-content/uploads/Screen-Shot-2022-05-28-at-12.14.49.png)
A company dedicated to controlled administration of gaseous nitric oxide to prevent risks of progressing hypoxic respiratory failure (HRF), which can be both acute and long-term.